Estimating the impact of better management of glycaemic control in adults with Type 1 and Type 2 diabetes on the number of clinical complications and the associated financial benefit

Diabetic Medicine

Volumn 33, Issue 11, 2016, Pages 1575-1581

  Baxter, M ^a   Hudson, R ^a   Mahon, J ^b   Bartlett, C ^b   Samyshkin, Y ^c   Alexiou, D ^c   Hex, N ^b  

^a Sanofi   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c IQVIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COST BENEFIT ANALYSIS; COST CONTROL; DIABETES CONTROL; DIABETIC NEUROPATHY; EYE DISEASE; FOOT ULCER; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; ULCER; AGED; BLOOD; COMPLICATION; DIABETIC COMPLICATION; ECONOMICS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; MALE; METABOLISM; MIDDLE AGED; UNITED KINGDOM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GLYCATED HEMOGLOBIN A; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; UNITED KINGDOM;

EID: 84963527073     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.13062     Document Type: Article

References (18)

1. Hex N, Bartlett C, Wright D, Taylor M, Varley D. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med 2012; 29: 855–862.
2. Huang E, Liu J, Moffet H, John P, Karter A. Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study. Diabetes Care 2011; 34: 1329–1336.
3. Clarke PM, Gray AM, Briggs A, Farmer AJ, Fenn P, Stevens RJ et al. A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia 2004; 47: 1747–1759.
4. Hayes AJ, Leal J, Gray AM, Holman RR, Clarke PM. UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS82. Diabetologia 2013; 56: 1925–1933.
5. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33. Lancet 1998; 352: 837–851.
6. The Diabetes Control and Complications Trial Research Group. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus. N Engl J Med 1993; 329: 977–986.
7. The National Collaborating Centre for Chronic Conditions. Type 2 Diabetes. National Clinical Guideline for Management in Primary and Secondary Care (update). London: Royal College of Physicians, 2008.
8. ™): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice. Diabetes Obes Metab 2012; 14: 654–661.
9. Khunti K, Wolden ML, Thorsted BL, Andersen M, Davies MJ. Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people. Diabetes Care 2013; 36: 3411–3417.
10. Khunti K, Vora J, Davies M. Results from the UK cohort of SOLVE: providing insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice. Prim Care Diabetes 2014; 8: 57–63.
11. Kostev K, Dippel FW, Rathmann W. Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis. Diabetes Metab Syndr Obes 2015; 8: 45–48.
12. McEwan P, Foos V, Palmer JL, Lamotte M, Lloyd A, Grant D. Validation of the IMS CORE Diabetes Model. Value Health 2014; 17: 714–724.
13. Editorials, Computer Modeling of Diabetes and Its Complications: A Report on the Fifth Mount Hood Challenge Meeting. Value in Health 2013; 16: 453–454.
14. The IMS CORE Diabetes Model. Available at http://www.core-diabetes.com/ Last accessed 3 June 2015.
15. Jansen JP. Self-monitoring of glucose in type 2 diabetes mellitus: a Bayesian meta-analysis of direct and indirect comparisons. Curr Med Res Opin 2006; 22: 671–681.
16. Personal Social Services Research Unit. Unit Costs of Health and Social Care, 2013. Available at http://www.pssru.ac.uk/project-pages/unit-costs/ Last accessed 3 June 2015.
17. NHS Diabetes. National Diabetes Inpatient Audit 2013. Available at http://www.hscic.gov.uk/catalogue/PUB13662/nati-diab-inp-audi-13-nat-rep.pdf Last accessed 29 April 2015.
18. The Action to Control Cardiovascular Risk in Diabetes. Study Group. Effects of Intensive Glucose Lowering in Type 2 Diabetes. N Engl J Med 2008; 358: 2545–2559.